One‐Pot RPA ‐ CRISPR /Cas12a Assay With Visual Readout for the Ultra‐Specific Detection of Monkeypox Virus Clade I
Microbial Biotechnology · 2026
DOI: 10.1111/1751-7915.70437 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbial Biotechnology, 2026. Verfasst von Boyi Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Monkeypox virus, Nucleic Acid Amplification Techniques, Mpox, Monkeypox. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, the science and technology development program of Jilin Province.
Abstract (Originalsprache)
In 2024, Monkeypox virus (MPXV) clade I has triggered outbreaks in several countries world‐wide. MPXV clade I demonstrates enhanced virulence and transmissibility, with a case fatality rate reaching 10%. In response, we have developed a one‐pot detection assay specifically targeting MPXV clade I, combining recombinase polymerase amplification (RPA) and the CRISPR/Cas12a system. The assay can be completed within 40 min and achieved a 95% limit of detection (LOD95) of 27.16 copies/μL. No cross‐reactivity was observed with MPXV clade II or other tested viral templates, including Vaccinia virus (Tiantan strain). A preliminary room‐temperature evaluation showed that the assay retained detectable performance at 25°C, supporting its potential use in equipment‐limited settings. The assay also showed good intra‐assay and inter‐assay repeatability for recombinant plasmid templates, with all coefficient of variation (CV) values below 10%. In simulated clinical samples, the RPA‐CRISPR/Cas12a assay detected more low‐concentration plasmid‐spiked samples than quantitative polymerase chain reaction (qPCR). These results indicate that the established assay is specific, sensitive, repeatable, and easy to perform, providing a practical tool for field‐based screening and decentralized detection of MPXV clade I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin Un…
- Zhili College, Tsinghua University, Beijing, China.
ORCID-Profile: Boyi Li, Luyao Liu, Kaikai Jin, Zanheng Huang, Tianyi Zhang, Rong Gao, Huanxin Chen, Lijuan Niu, Changqi Fan, Haili Zhang, Pei Huang, Hualei Wang
Förderung
- National Key Research and Development Program of China
- the science and technology development program of Jilin Province
Zitieren
APA
Li, B., Liu, L., Jin, K., Huang, Z., Zhang, T., Gao, R., Chen, H., Niu, L., Fan, C., Zhang, H., Huang, P., & Wang, H. (2026). One‐Pot RPA ‐ CRISPR /Cas12a Assay With Visual Readout for the Ultra‐Specific Detection of Monkeypox Virus Clade I. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.70437
Vancouver
Li B, Liu L, Jin K, Huang Z, Zhang T, Gao R, et al. One‐Pot RPA ‐ CRISPR /Cas12a Assay With Visual Readout for the Ultra‐Specific Detection of Monkeypox Virus Clade I. Microbial Biotechnology. 2026. doi:10.1111/1751-7915.70437
BibTeX
@article{Li2026,
author = {Li, Boyi and Liu, Luyao and Jin, Kaikai and Huang, Zanheng and Zhang, Tianyi and Gao, Rong and Chen, Huanxin and Niu, Lijuan and Fan, Changqi and Zhang, Haili and Huang, Pei and Wang, Hualei},
title = {One‐Pot RPA ‐ CRISPR /Cas12a Assay With Visual Readout for the Ultra‐Specific Detection of Monkeypox Virus Clade I},
journal = {Microbial Biotechnology},
year = {2026},
doi = {10.1111/1751-7915.70437}
}
EUVIMED